FDA announced that it has raised the ceiling on its Business Transformation Team BPA, awarded to Deloitte, KPMG and PwC, by $30M each, raising each of the awards from an initial $103M to $133M.
The BPA is intended to provide FDA with support to develop evaluation capacity, improve decision making and risk management through systematic inquiry, strategic alignment to ensure mission effectiveness, and facilitate change across FDA’s centrally provided administrative functions.
